Abstract
Introduction
Dipyrone is an analgesic and antipyretic agent. The purpose of this study was to describe the pattern of dipyrone exposures reported to poison centers.
Methods
Human dipyrone exposures reported to 6 Texas poison centers from 1998 to 2004 were identified. Isolated and non-isolated cases were compared with respect to various factors.
Results
When compared to the Census, dipyrone exposures were significantly more likely to have been reported from regions closer to the Mexican border (53% vs 9%). Of 81 dipyrone exposures, 52 (64%) were isolated and 29 (36%) were non-isolated. Most of the dipyrone exposures occurred at the patient’s own residence (72/76 or 95%) and the patients were more likely to be female (54/81 or 67%). Although the majority of both types of dipyrone exposures were adults (47/78 or 60%), children, less than 6 years of age, accounted for a higher proportion of isolated exposures (33% vs 10%) while a higher proportion of non-isolated exposures involved older children (28% vs 8%). Twenty-two percent (11/51) of isolated cases were intentional while 59% (17/29) of non-isolated cases were intentional. Of those cases with a known medical outcome, the medical outcome was no adverse clinical effect for 76% (16/21) of isolated exposures and 42% (8/19) of non-isolated exposures. The specific adverse clinical effects reported for isolated exposures were primarily neurological (n = 6), gastrointestinal (n = 4), and dermal (n = 3). The most frequently reported treatment for isolated exposures was some form of decontamination (n = 11).
Conclusions
Isolated and non-isolated dipyrone exposures varied with respect to patient age, exposure reason, management site, medical outcome.
Keywords: dipyrone, poison centers, adverse exposures
Full Text
The Full Text of this article is available as a PDF (131.3 KB).
Footnotes
Funding for this research was provided by a contract with the Commission on State Emergency Communications in Texas.
References
- 1.Abbate R, Pinto S, Gori AM, Paniccia R, Coppo M, Neri Serneri GG. Activity of dipyrone on intraplatelet arachidonic acid metabolism: an in vitro study. Pharmacol Res. 1989;21:43–50. doi: 10.1016/1043-6618(89)90120-5. [DOI] [PubMed] [Google Scholar]
- 2.Abbate R, Gori AM, Pinto S, Attanasio M, Paniccia R, Coppo M, et al. Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone. Prostaglandins Leukot Essent Fatty Acids. 1990;41:89–93. doi: 10.1016/0952-3278(90)90059-T. [DOI] [PubMed] [Google Scholar]
- 3.Frolich JC, Rupp WA, Zapf RM, Badian MJ. The effects of metamizol on prostaglandin synthesis in man. Agents Actions Suppl. 1986;19:155–166. [PubMed] [Google Scholar]
- 4.Bentur Y, Cohen O. Dipyrone overdose. J Toxicol Clin Toxicol. 2003;42:261–265. doi: 10.1081/CLT-120037425. [DOI] [PubMed] [Google Scholar]
- 5.Bozzini L, Bunch C. Dipyrone. Micromedex (R) Health Care Series. Greenwood Village, Colorado: Micromedex, Inc.; 2000. [Google Scholar]
- 6.Lugo AM. Mexican border medications: potential toxicity. J Toxicol Clin Toxicol. 1999;37:121–123. doi: 10.1081/CLT-100102512. [DOI] [PubMed] [Google Scholar]
- 7.Taylor L, Abarca S, Henry B, Friedman L. Use of Neomelubrina, a banned antipyretic drug, in San Diego, California: a survey of patients and providers. West J Med. 2001;175:159–163. doi: 10.1136/ewjm.175.3.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bonkowsky JL, Frazer JK, Buchi KF, Byington CL. Metamizole use by Latino immigrants: a common and potentially harmful home remedy. Pediatrics. 2002;109:e98–e98. doi: 10.1542/peds.109.6.e98. [DOI] [PubMed] [Google Scholar]
- 9.Anderson JA, Adkinson NF. Allergic reactions to drugs and biologic agents. JAMA. 1987;258:2891–2899. doi: 10.1001/jama.258.20.2891. [DOI] [PubMed] [Google Scholar]
- 10.Arndt KA, Jick H. Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program. JAMA. 1976;235:918–923. doi: 10.1001/jama.235.9.918. [DOI] [PubMed] [Google Scholar]